Avatar feed
Responses: 4
SGT Program Coordinator
2
2
0
Well, here at work, there are some, they say that they're alive, but with their work, they're dead.
(2)
Comment
(0)
Avatar small
MSG Chief Executive Officer (Ceo)
2
2
0
These places need to pay closer attention to vitals and stop automatically deferring to discarding our senior citizens as second class or society's excess. My heart goes out to these people.
(2)
Comment
(0)
Avatar small
SGT Unit Supply Specialist
1
1
0
PO1 William "Chip" Nagel DUH!
..."COVID vaccine makers are poised to raise prices
Take vaccines. Until now, the federal government has been purchasing COVID-19 shots. It recently bought 105 million doses of the Pfizer-BioNTech bivalent booster for about $30.48 a dose, and 66 million doses of Moderna's version for $26.36 a dose. (These are among the companies that developed the first COVID vaccines sold in the United States.)

People will be able to get these vaccines at low or no cost as long as the government-purchased supplies last. But even before the end date for the public emergency was set, Congress opted not to provide more money to increase the government's dwindling stockpile. As a result, Pfizer and Moderna were already planning their moves into the commercial market. Both have indicated that as soon as that happens, they will raise the price they charge, somewhere in the range of $110 to $130 per dose, though insurers and government health programs could negotiate lower rates.

"We see a double-digit billion[-dollar] market opportunity," investors were told at a JPMorgan conference in San Francisco recently by Ryan Richardson, chief strategy officer for BioNTech. The company expects a gross price — the full price before any discounts — of $110 a dose, which, Richardson said, "is more than justified from a health economics perspective."...
(1)
Comment
(0)
Avatar small

Join nearly 2 million former and current members of the US military, just like you.

close